𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunosuppression by the radiation leukemia virus and its relation to lymphatic leukemia development

✍ Scribed by Alpha Peled; Nechama Haran-Ghera

Publisher
John Wiley and Sons
Year
1971
Tongue
French
Weight
699 KB
Volume
8
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The immune response of C57BL/6 mice following intra‐thymic injection of the radiation leukemia virus was tested. A marked depression in plaque‐forming capacity of the 19S type to sheep red cells was observed in adult intact and thymectomized mice inoculated with the virus 5–60 days prior to the immunization. Serum hemagglutinin titers were depressed as well, but to a lesser degree.

The radiation leukemia virus did not significantly depress cell‐mediated immunity. Tests for prolongation of skin allograft survival, allogeneic tumor takes and graft‐versus‐host reactivity (Simonsen's test) were used as parameters for the evaluation of defects in cellular immunity.

No correlation was found between the immunosuppressive effect of the radiation leukemia virus and lymphatic leukemia development.

It is proposed that the decrease observed, with aging, in the immune response of normal C57BL mice, to sheep red cells, is due to the radiation leukemia virus that is present during post‐natal life in non‐irradiated C57BL mice, and that its titer increases with aging.

📜 SIMILAR VOLUMES

High- and low-leukemogenic variants of t
High- and low-leukemogenic variants of the radiation leukemia virus (RadLV): Immunogenic, suppressive and genetic properties in relation to leukemogenic activity
✍ Eitan Yefenof; Ya'acob Ben David; Moshe Kotler 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 819 KB

C57BL/6 (B6) mice inoculated with the highly leukemogenic variant of the radiation leukemia virus (A-RadLV) develop suppressor cells capable of abrogating potential anti-tumor immunity in vitro and in vivo. Inoculation of B6 animals with the low-leukemogenic D-RadLV variant does not result in suppre

The moloney murine leukemia virus enhanc
The moloney murine leukemia virus enhancer and its flanking sequences collaborate to determine virulence in T-cell lymphomagenesis
✍ Pick-Hoong Yuen; Yong-Ho Khang; Abhay Kumar; Paul F. Szurek; Elizabeth A. Maull 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 763 KB

A panel of recombinant virus genomes was constructed by exchanging homologous genome fragments between the potent T-cell lymphoma inducer Moloney murine leukemia virus (MoMuLV) and its closely related but significantly less virulent relative MoMuLV-TB. Testing of these recombinant viruses in BALB/c

High- and low-leukemogenic variants of t
High- and low-leukemogenic variants of the radiation leukemia virus (RadLV) differ in ability to induce tumor-specific immune suppression
✍ Eitan Yefenof; David Zilcha 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 494 KB

## Abstract Adult C57BL/6 mice inoculated intrathymically (i.t.) with the highly leukemogenic variant of the radiation leukemia virus (A‐RadLV) develop suppressor cells capable of specifically abrogating a potential anti‐tumor cytotoxic response __in vitro__. Suppressor cells were generated directl

Induction of IL-4 secretion by the radia
Induction of IL-4 secretion by the radiation leukemia virus (RadLV): Role in autocrine growth stimulation of RadLV infected pre-leukemic cells
✍ Eitan Yefenof; Catherine Ela; Moshe Kotler; Ellen S. Vitetta 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 598 KB

lntrathymic inoculation of radiation-leukemia virus (RadLV) into C57BL/6 mice induces a population of pre-leukemic (PL) T cells which progress into clonal, mature thymic lymphomas after a latency period of 3 to 5 months. In order to understand how PL cells are retained in the thymus for a prolonged